| Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults S Seidler, HW Zimmermann, M Bartneck, C Trautwein, F Tacke BMC immunology 11, 1-11, 2010 | 424 | 2010 |
| A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis J Gautheron, M Vucur, F Reisinger, DV Cardenas, C Roderburg, C Koppe, ... EMBO molecular medicine 6 (8), 1062-1074, 2014 | 325 | 2014 |
| CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis J Ehling, M Bartneck, X Wei, F Gremse, V Fech, D Möckel, C Baeck, ... Gut 63 (12), 1960-1971, 2014 | 322 | 2014 |
| Pharmacological inhibition of the chemokine C‐C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly‐6C+ … C Baeck, X Wei, M Bartneck, V Fech, F Heymann, N Gassler, K Hittatiya, ... Hepatology 59 (3), 1060-1072, 2014 | 281 | 2014 |
| Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry M Bartneck, HA Keul, S Singh, K Czaja, J Bornemann, M Bockstaller, ... ACS nano 4 (6), 3073-3086, 2010 | 269 | 2010 |
| Phagocytosis independent extracellular nanoparticle clearance by human immune cells M Bartneck, HA Keul, G Zwadlo-Klarwasser, J Groll Nano letters 10 (1), 59-63, 2010 | 251 | 2010 |
| Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice F Heymann, L Hammerich, D Storch, M Bartneck, S Huss, V Rüsseler, ... Hepatology 55 (3), 898-909, 2012 | 192 | 2012 |
| Peptide-functionalized gold nanorods increase liver injury in hepatitis M Bartneck, T Ritz, HA Keul, M Wambach, J Bornemann, U Gbureck, ... Acs Nano 6 (10), 8767-8777, 2012 | 175 | 2012 |
| Therapeutic targeting of liver inflammation and fibrosis by nanomedicine M Bartneck, KT Warzecha, F Tacke Hepatobiliary surgery and nutrition 3 (6), 364, 2014 | 171 | 2014 |
| Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface NE Paul, C Skazik, M Harwardt, M Bartneck, B Denecke, D Klee, J Salber, ... Biomaterials 29 (30), 4056-4064, 2008 | 160 | 2008 |
| Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres M Bartneck, KH Heffels, Y Pan, M Bovi, G Zwadlo-Klarwasser, J Groll Biomaterials 33 (16), 4136-4146, 2012 | 155 | 2012 |
| Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases M Bartneck, KM Scheyda, KT Warzecha, LY Rizzo, K Hittatiya, T Luedde, ... Biomaterials 37, 367-382, 2015 | 147 | 2015 |
| Induction of specific macrophage subtypes by defined micro-patterned structures M Bartneck, VA Schulte, NE Paul, M Diez, MC Lensen, ... Acta biomaterialia 6 (10), 3864-3872, 2010 | 114 | 2010 |
| Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages M Bartneck, FM Peters, KT Warzecha, M Bienert, L van Bloois, ... Nanomedicine: nanotechnology, biology and medicine 10 (6), 1209-1220, 2014 | 112 | 2014 |
| Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis HT Schon, M Bartneck, E Borkham-Kamphorst, J Nattermann, T Lammers, ... Frontiers in pharmacology 7, 33, 2016 | 109 | 2016 |
| Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease M Bartneck, V Fech, J Ehling, O Govaere, KT Warzecha, K Hittatiya, ... Hepatology 63 (4), 1310-1324, 2016 | 105 | 2016 |
| The CCR2+ macrophage subset promotes pathogenic angiogenesis for tumor vascularization in fibrotic livers M Bartneck, PL Schrammen, D Möckel, O Govaere, A Liepelt, O Krenkel, ... Cellular and molecular gastroenterology and hepatology 7 (2), 371-390, 2019 | 102 | 2019 |
| The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance J Gautheron, M Vucur, AT Schneider, I Severi, C Roderburg, S Roy, ... Nature Communications 7 (1), 11869, 2016 | 88 | 2016 |
| Prognostic relevance of altered lymphocyte subpopulations in critical illness and sepsis P Hohlstein, H Gussen, M Bartneck, KT Warzecha, C Roderburg, ... Journal of clinical medicine 8 (3), 353, 2019 | 87 | 2019 |
| Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles C Ergen, F Heymann, F Gremse, M Bartneck, U Panzer, R Pola, M Pechar, ... Biomaterials 114, 106-120, 2017 | 82 | 2017 |
